Exchange: NASDAQ·Updated 10:12 AM EDT
SRZN logo

SRZN Surrozen Inc

$21.92
$0.62
(2.75%)
Today
Reported EarningsAug 6
Mkt Cap$264.93M
Vol9,302.00

About SRZN

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
50

Neutral Sentiment

How do you feel about SRZN?

Advertisement|Remove ads.